Skip to content

Clinical trials

Phase 2 Liver Cirrhosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 2 Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20111
20124
20133
20143
20153
20162
20173
20187
20193
20201
20213
20224
20236
20246
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting11
Terminated10
Unknown status3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Conatus Pharmaceuticals Inc.5
Gilead Sciences5
Bristol-Myers Squibb3
Boehringer Ingelheim2
Hepion Pharmaceuticals, Inc.2
University of Texas Southwestern Medical Center2
Atea Pharmaceuticals, Inc.1
Axcella Health, Inc1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis56
Non-alcoholic Fatty Liver Disease19
Fibrosis11
Carcinoma, Hepatocellular5
Hepatic Encephalopathy5
Hepatitis C5
Hypertension, Portal5
Liver Diseases4
Fatty Liver3
Ascites2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.